In Alzheimer's disease (AD), cystatin C has been shown to have a neuroprotective action by inducing autophagy, inhibiting cysteine proteases and by inhibiting amyloid-β aggregation [32]. This evidence concerns the gene CTSB and early-onset autosomal dominant Alzheimer disease.